1. Home
  2. PTGX vs LILAK Comparison

PTGX vs LILAK Comparison

Compare PTGX & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • LILAK
  • Stock Information
  • Founded
  • PTGX 2006
  • LILAK 2017
  • Country
  • PTGX United States
  • LILAK Bermuda
  • Employees
  • PTGX N/A
  • LILAK N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • LILAK Cable & Other Pay Television Services
  • Sector
  • PTGX Health Care
  • LILAK Telecommunications
  • Exchange
  • PTGX Nasdaq
  • LILAK Nasdaq
  • Market Cap
  • PTGX 3.3B
  • LILAK 1.1B
  • IPO Year
  • PTGX 2016
  • LILAK N/A
  • Fundamental
  • Price
  • PTGX $53.00
  • LILAK $6.34
  • Analyst Decision
  • PTGX Strong Buy
  • LILAK Buy
  • Analyst Count
  • PTGX 9
  • LILAK 3
  • Target Price
  • PTGX $67.11
  • LILAK $10.27
  • AVG Volume (30 Days)
  • PTGX 923.4K
  • LILAK 1.2M
  • Earning Date
  • PTGX 08-05-2025
  • LILAK 08-05-2025
  • Dividend Yield
  • PTGX N/A
  • LILAK N/A
  • EPS Growth
  • PTGX N/A
  • LILAK N/A
  • EPS
  • PTGX 0.86
  • LILAK N/A
  • Revenue
  • PTGX $207,801,000.00
  • LILAK $4,441,000,000.00
  • Revenue This Year
  • PTGX N/A
  • LILAK $2.45
  • Revenue Next Year
  • PTGX $53.09
  • LILAK $3.11
  • P/E Ratio
  • PTGX $61.48
  • LILAK N/A
  • Revenue Growth
  • PTGX N/A
  • LILAK N/A
  • 52 Week Low
  • PTGX $32.50
  • LILAK $4.23
  • 52 Week High
  • PTGX $60.60
  • LILAK $10.93
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 53.99
  • LILAK 61.36
  • Support Level
  • PTGX $49.38
  • LILAK $5.92
  • Resistance Level
  • PTGX $51.51
  • LILAK $6.65
  • Average True Range (ATR)
  • PTGX 2.02
  • LILAK 0.31
  • MACD
  • PTGX -0.39
  • LILAK 0.01
  • Stochastic Oscillator
  • PTGX 46.09
  • LILAK 68.37

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About LILAK Liberty Latin America Ltd. Class C

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: